Health ❯ Healthcare ❯ Regulations

FDA

Drug Safety Drug Approval Process Drug Approval Processes Good Manufacturing Practices Drug Compounding Drug Shortages Drug Approval Stem Cell Therapy Policy Changes Current Good Manufacturing Practices Clinical Trials Software as a Medical Device Labeling Changes Mifepristone HHS Drug Classifications Clinical Decision Support Software Recalls General Wellness Products Botulinum Toxin Vaccine Guidelines Drug Recalls Priority Review Vouchers Drug Approvals Wellness Devices iPLEDGE REMS Cell and Gene Therapies Prohibited Treatments Product Recalls Drug Enforcement Compounding Pharmacies Compounded Medications Mammography Guidelines Medical Device Recalls

FDA Approves Vanda's Bysanti for Schizophrenia and Bipolar I in Adults

Vanda frames the drug as a bioequivalent successor to iloperidone, leveraging Fanapt’s clinical experience.

Honey Energy Supplement Recalled After FDA Finds Undeclared ED Drug

FDA Eases CMC Rules for Cell and Gene Therapies to Speed Development

FDA Eases Oversight of Wearables and Clinical Decision Support in Final Guidance

FDA Adds Boxed Liver Warning and Limits Elevidys to Ambulatory Boys 4 and Up

Moderna Trims 2025 Forecast as Q3 Loss Narrows and Revenue Beats

FDA Class II Recall Targets 580,000 Prazosin Bottles for Nitrosamine Overages

Louisiana Warns After Two Hospitalizations Tied to Unlicensed Botox Injections

FDA Sends Mass Warnings, Seeks to End 1997 Drug Ad Rule After White House Directive

Khloé Kardashian Shares Mexico Stem Cell Infusion Not Allowed in the U.S.

Tandem Diabetes Announces Urgent Medical Device Correction for t:slim X2 Pumps

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves